An international collaboration involving the late UdeM neuroscientist highlights a new therapeutic target for Fragile X syndrome, a leading cause of autism and intellectual disability.

In an UdeM-led clinical trial at Hôpital Maisonneuve-Rosemont, a patient is treated with a special kind of immunotherapy for lupus, myositis, scleroderma and other diseases.

Our expert David Ogez answers our questions about hypnosis and what it can do to help goaltenders and other professional athletes get in the right mindset to win games.